{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:43:19Z","timestamp":1781664199414,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s11739-024-03758-6","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T04:02:33Z","timestamp":1725508953000},"page":"105-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: a nationwide cohort study"],"prefix":"10.1007","volume":"20","author":[{"given":"So Hee","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungkuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Yoon","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Bin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyuri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Man","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Yeon","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-963X","authenticated-orcid":false,"given":"Jae Hyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"3758_CR1","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, International Diabetes Federation Task Force on E, Prevention, Hational Heart L, Blood I, American Heart A, World Heart F, International Atherosclerosis S, International Association for the Study of O (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640\u20131645","journal-title":"Circulation"},{"key":"3758_CR2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","volume":"2","author":"H Yki-J\u00e4rvinen","year":"2014","unstructured":"Yki-J\u00e4rvinen H (2014) Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2:901\u2013910","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3758_CR3","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","volume":"142","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ, American Gastroenterological A, American Association for the Study of Liver D, American College of G (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142:1592\u20131609","journal-title":"Gastroenterology"},{"key":"3758_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.14.185","volume":"14","author":"RS Rector","year":"2008","unstructured":"Rector RS, Thyfault JP, Wei Y, Ibdah JA (2008) Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 14:185\u2013192","journal-title":"World J Gastroenterol"},{"key":"3758_CR5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L (2023) The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77:1335\u20131347","journal-title":"Hepatology"},{"key":"3758_CR6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413\u20131419","journal-title":"Gastroenterology"},{"key":"3758_CR7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","volume":"6","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Csermely A, Petracca G, Beatrice G, Corey KE, Simon TG, Byrne CD, Targher G (2021) Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol 6:903\u2013913","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3758_CR8","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","volume":"70","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G (2021) Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut 70:962\u2013969","journal-title":"Gut"},{"key":"3758_CR9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","volume":"71","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Schattenberg JM, Tilg H, Byrne CD, Targher G (2022) Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut 71:156\u2013162","journal-title":"Gut"},{"key":"3758_CR10","volume":"5","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Zhang T, Zhang C, Tang F, Zhong N, Li H, Song X, Lin H, Liu Y, Xue F (2015) Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population. BMJ Open 5:e008204","journal-title":"BMJ Open"},{"key":"3758_CR11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/ijms17030367","volume":"17","author":"P Wainwright","year":"2016","unstructured":"Wainwright P, Byrne CD (2016) Bidirectional relationships and disconnects between NAFLD and features of the metabolic syndrome. Int J Mol Sci 17:367","journal-title":"Int J Mol Sci"},{"key":"3758_CR12","volume":"45","author":"HJ Im","year":"2021","unstructured":"Im HJ, Ahn YC, Wang JH, Lee MM, Son CG (2021) Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea. Clin Res Hepatol Gastroenterol 45:101526","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3758_CR13","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100873","volume":"28","author":"D Contreras","year":"2023","unstructured":"Contreras D, Gonz\u00e1lez-Rocha A, Clark P, Barquera S, Denova-Guti\u00e9rrez E (2023) Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: systematic review and meta-analysis. Ann Hepatol 28:100873","journal-title":"Ann Hepatol"},{"key":"3758_CR14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/hepr.13790","volume":"52","author":"K Mori","year":"2022","unstructured":"Mori K, Tanaka M, Higashiura Y, Hanawa N, Ohnishi H, Furuhashi M (2022) High fatty liver index is an independent predictor of ischemic heart disease during a 10-year period in a Japanese population. Hepatol Res 52:687\u2013698","journal-title":"Hepatol Res"},{"key":"3758_CR15","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s11739-021-02682-3","volume":"16","author":"D Pastori","year":"2021","unstructured":"Pastori D, Sciacqua A, Marcucci R, Del Ben M, Baratta F, Violi F, Pignatelli P, group A-As (2021) Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study. Intern Emerg Med 16:2063\u20132068","journal-title":"Intern Emerg Med"},{"key":"3758_CR16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12872-020-01444-x","volume":"20","author":"JH Roh","year":"2020","unstructured":"Roh JH, Park JH, Lee H, Yoon YH, Kim M, Kim YG, Park GM, Lee JH, Seong IW (2020) Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: a Nationwide Population-Based Study in Korea. BMC Cardiovasc Disord 20:204","journal-title":"BMC Cardiovasc Disord"},{"key":"3758_CR17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4093\/dmj.2014.38.5.395","volume":"38","author":"SO Song","year":"2014","unstructured":"Song SO, Jung CH, Song YD, Park CY, Kwon HS, Cha BS, Park JY, Lee KU, Ko KS, Lee BW (2014) Background and data configuration process of a nationwide population-based study using the Korean National Health Insurance System. Diabetes Metab J 38:395\u2013403","journal-title":"Diabetes Metab J"},{"key":"3758_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12933-020-01025-4","volume":"19","author":"JH Kim","year":"2020","unstructured":"Kim JH, Moon JS, Byun SJ, Lee JH, Kang DR, Sung KC, Kim JY, Huh JH (2020) Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study. Cardiovasc Diabetol 19:51","journal-title":"Cardiovasc Diabetol"},{"key":"3758_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12933-021-01374-8","volume":"20","author":"J Park","year":"2021","unstructured":"Park J, Kim G, Kim H, Lee J, Lee YB, Jin SM, Hur KY, Kim JH (2021) The association of hepatic steatosis and fibrosis with heart failure and mortality. Cardiovasc Diabetol 20:197","journal-title":"Cardiovasc Diabetol"},{"key":"3758_CR20","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/jdi.13539","volume":"12","author":"YB Lee","year":"2021","unstructured":"Lee YB, Han K, Kim B, Choi MS, Park J, Kim M, Jin SM, Hur KY, Kim G, Kim JH (2021) Risk of early mortality and cardiovascular disease according to the presence of recently diagnosed diabetes and requirement for insulin treatment: A Nationwide Study. J Diabetes Investig 12:1855\u20131863","journal-title":"J Diabetes Investig"},{"key":"3758_CR21","doi-asserted-by":"crossref","first-page":"12716","DOI":"10.1038\/s41598-017-13061-4","volume":"7","author":"HY Lee","year":"2017","unstructured":"Lee HY, Yang PS, Kim TH, Uhm JS, Pak HN, Lee MH, Joung B (2017) Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study. Sci Rep 7:12716","journal-title":"Sci Rep"},{"key":"3758_CR22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2337\/dc17-1590","volume":"41","author":"SH Wild","year":"2018","unstructured":"Wild SH, Walker JJ, Morling JR, McAllister DA, Colhoun HM, Farran B, McGurnaghan S, McCrimmon R, Read SH, Sattar N, Byrne CD, Epid SDRN (2018) Cardiovascular Disease, Cancer, and mortality among people with Type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission. Diabetes Care 41:341\u2013347","journal-title":"Diabetes Care"},{"key":"3758_CR23","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","volume":"53","author":"ZM Younossi","year":"2011","unstructured":"Younossi ZM, Stepanova M, Rafiq N, Makhlouf H, Younoszai Z, Agrawal R, Goodman Z (2011) Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 53:1874\u20131882","journal-title":"Hepatology"},{"key":"3758_CR24","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1093\/eurheartj\/ehx585","volume":"38","author":"MK Kim","year":"2017","unstructured":"Kim MK, Han K, Kim HS, Park YM, Kwon HS, Yoon KH, Lee SH (2017) Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study. Eur Heart J 38:3560\u20133566","journal-title":"Eur Heart J"},{"key":"3758_CR25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.diabres.2006.04.013","volume":"75","author":"SY Lee","year":"2007","unstructured":"Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB, Oh SJ, Park CY, Yoo HJ (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75:72\u201380","journal-title":"Diabetes Res Clin Pract"},{"key":"3758_CR26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6:33","journal-title":"BMC Gastroenterol"},{"key":"3758_CR27","volume":"94","author":"X Huang","year":"2015","unstructured":"Huang X, Xu M, Chen Y, Peng K, Huang Y, Wang P, Ding L, Lin L, Xu Y, Chen Y, Lu J, Wang W, Bi Y, Ning G (2015) Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine (Baltimore) 94:e1682","journal-title":"Medicine (Baltimore)"},{"key":"3758_CR28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA (2008) Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 57:1441\u20131447","journal-title":"Gut"},{"key":"3758_CR29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.metabol.2012.08.005","volume":"62","author":"ZM Younossi","year":"2013","unstructured":"Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A (2013) In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 62:352\u2013360","journal-title":"Metabolism"},{"key":"3758_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.metabol.2016.06.009","volume":"66","author":"AJ Karajamaki","year":"2017","unstructured":"Karajamaki AJ, Bloigu R, Kauma H, Kesaniemi YA, Koivurova OP, Perkiomaki J, Huikuri H, Ukkola O (2017) Non-alcoholic fatty liver disease with and without metabolic syndrome: different long-term outcomes. Metabolism 66:55\u201363","journal-title":"Metabolism"},{"key":"3758_CR31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","volume":"65","author":"SM Francque","year":"2016","unstructured":"Francque SM, van der Graaff D, Kwanten WJ (2016) Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications. J Hepatol 65:425\u2013443","journal-title":"J Hepatol"},{"key":"3758_CR32","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, Hagstr\u00f6m H, Nasr P, Fredrikson M, St\u00e5l P, Kechagias S, Hultcrantz R (2015) Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61:1547\u20131554","journal-title":"Hepatology"},{"key":"3758_CR33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12933-018-0670-7","volume":"17","author":"A Tuttolomondo","year":"2018","unstructured":"Tuttolomondo A, Petta S, Casuccio A, Maida C, Corte VD, Daidone M, Di Raimondo D, Pecoraro R, Fonte R, Cirrincione A, Zafonte R, Cabibi D, Camm\u00e0 C, Di Marco V, Licata A, Magliozzo F, Marchesini G, Merlino G, Crax\u00ec A, Pinto A (2018) Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. Cardiovasc Diabetol 17:28","journal-title":"Cardiovasc Diabetol"},{"key":"3758_CR34","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003446","volume":"95","author":"S Petta","year":"2016","unstructured":"Petta S, Tuttolomondo A, Gagliardo C, Zafonte R, Brancatelli G, Cabibi D, Camm\u00e0 C, Di Marco V, Galvano L, La Tona G, Licata A, Magliozzo F, Maida C, Marchesini G, Merlino G, Midiri M, Parrinello G, Torres D, Pinto A, Crax\u00ec A (2016) The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease. Medicine (Baltimore) 95:e3446","journal-title":"Medicine (Baltimore)"},{"key":"3758_CR35","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.22845","volume":"49","author":"A Gastaldelli","year":"2009","unstructured":"Gastaldelli A, Kozakova M, H\u00f8jlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B (2009) Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 49:1537\u20131544","journal-title":"Hepatology"},{"key":"3758_CR36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-0043-118667","volume":"126","author":"A Klisic","year":"2018","unstructured":"Klisic A, Isakovic A, Kocic G, Kavaric N, Jovanovic M, Zvrko E, Skerovic V, Ninic A (2018) Relationship between oxidative stress, inflammation and dyslipidemia with fatty liver index in patients with Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 126:371\u2013378","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"3758_CR37","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1080\/07853890.2021.1956685","volume":"53","author":"DJ Cuthbertson","year":"2021","unstructured":"Cuthbertson DJ, Koskinen J, Brown E, Magnussen CG, Hutri-K\u00e4h\u00f6nen N, Sabin M, Tossavainen P, Jokinen E, Laitinen T, Viikari J, Raitakari OT, Juonala M (2021) Fatty liver index predicts incident risk of prediabetes, Type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). Ann Med 53:1256\u20131264","journal-title":"Ann Med"},{"key":"3758_CR38","doi-asserted-by":"crossref","first-page":"12830","DOI":"10.1038\/s41598-021-92292-y","volume":"11","author":"Y Higashiura","year":"2021","unstructured":"Higashiura Y, Furuhashi M, Tanaka M, Takahashi S, Koyama M, Ohnishi H, Numata K, Hisasue T, Hanawa N, Moniwa N, Tsuchihashi K, Miura T (2021) High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects. Sci Rep 11:12830","journal-title":"Sci Rep"},{"key":"3758_CR39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12902-022-01030-6","volume":"22","author":"J Qu","year":"2022","unstructured":"Qu J, Dou J, Wang A, Liu Y, Lin L, Chen K, Zang L, Mu Y (2022) Fatty liver index for hyperuricemia diagnosis: a community-based cohort study. BMC Endocr Disord 22:114","journal-title":"BMC Endocr Disord"},{"key":"3758_CR40","volume":"34","author":"JY Jung","year":"2019","unstructured":"Jung JY, Park SK, Oh CM, Chung PW, Ryoo JH (2019) Non-alcoholic fatty liver disease and its association with depression in Korean general population. J Korean Med Sci 34:e199","journal-title":"J Korean Med Sci"},{"key":"3758_CR41","volume":"13","author":"L Lampignano","year":"2021","unstructured":"Lampignano L, Donghia R, Griseta C, Lagravinese G, Sciarra S, Zupo R, Castellana F, Bortone I, Guerra V, Tirelli S, De Nucci S, Tatoli R, Lozupone M, Sborgia G, Leo A, De Pergola G, Giannelli G, Panza F, Sardone R (2021) Liver health and dementia in an italian older population: findings from the salus in Apulia Study. Front Aging Neurosci 13:748888","journal-title":"Front Aging Neurosci"},{"key":"3758_CR42","volume":"17","author":"N Kim","year":"2022","unstructured":"Kim N, Roh JH, Lee H, Kim D, Heo SJ (2022) The impact of non-alcoholic fatty liver disease on sleep apnea in healthy adults: a Nationwide Study of Korea. PLoS One 17:e0271021","journal-title":"PLoS One"},{"key":"3758_CR43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12916-022-02460-8","volume":"20","author":"S Wu","year":"2022","unstructured":"Wu S, Yuan C, Yang Z, Liu S, Zhang Q, Zhang S, Zhu S (2022) Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study. BMC Med 20:262","journal-title":"BMC Med"},{"key":"3758_CR44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.24356","volume":"54","author":"G Calori","year":"2011","unstructured":"Calori G, Lattuada G, Ragogna F, Garancini MP, Crosignani P, Villa M, Bosi E, Ruotolo G, Piemonti L, Perseghin G (2011) Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 54:145\u2013152","journal-title":"Hepatology"},{"key":"3758_CR45","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155222","volume":"133","author":"GE Chung","year":"2022","unstructured":"Chung GE, Jeong SM, Cho EJ, Yoo JJ, Cho Y, Lee KN, Shin DW, Kim YJ, Yoon JH, Han K, Yu SJ (2022) Association of fatty liver index with all-cause and disease-specific mortality: a Nationwide Cohort Study. Metabolism 133:155222","journal-title":"Metabolism"},{"key":"3758_CR46","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/diagnostics12030663","volume":"12","author":"B Han","year":"2022","unstructured":"Han B, Lee GB, Yim SY, Cho KH, Shin KE, Kim JH, Park YG, Han KD, Kim YH (2022) Non-alcoholic fatty liver disease defined by fatty liver index and incidence of heart failure in the Korean population: a Nationwide Cohort Study. Diagnostics (Basel) 12:663","journal-title":"Diagnostics (Basel)"},{"key":"3758_CR47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142210","volume":"10","author":"S Petta","year":"2015","unstructured":"Petta S, Marrone O, Torres D, Buttacavoli M, Camm\u00e0 C, Di Marco V, Licata A, Lo Bue A, Parrinello G, Pinto A, Salvaggio A, Tuttolomondo A, Crax\u00ec A, Bonsignore MR (2015) Obstructive sleep apnea is associated with liver damage and atherosclerosis in patients with non-alcoholic fatty liver disease. PLoS One 10:e0142210","journal-title":"PLoS One"},{"key":"3758_CR48","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/apt.12609","volume":"39","author":"J Shen","year":"2014","unstructured":"Shen J, Wong GL, Chan HL, Chan HY, Yeung DK, Chan RS, Chim AM, Chan AW, Choi PC, Woo J, Chu WC, Wong VW (2014) PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome. Aliment Pharmacol Ther 39:532\u2013539","journal-title":"Aliment Pharmacol Ther"},{"key":"3758_CR49","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","volume":"53","author":"S Sookoian","year":"2011","unstructured":"Sookoian S, Pirola CJ (2011) Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53:1883\u20131894","journal-title":"Hepatology"},{"key":"3758_CR50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/ijms17050633","volume":"17","author":"EM Pet\u00e4j\u00e4","year":"2016","unstructured":"Pet\u00e4j\u00e4 EM, Yki-J\u00e4rvinen H (2016) Definitions of normal liver fat and the association of insulin sensitivity with acquired and genetic NAFLD-a systematic review. Int J Mol Sci 17:633","journal-title":"Int J Mol Sci"},{"key":"3758_CR51","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cgh.2019.08.011","volume":"18","author":"S Grimaudo","year":"2020","unstructured":"Grimaudo S, Pipitone RM, Pennisi G, Celsa C, Camm\u00e0 C, Di Marco V, Barcellona MR, Boemi R, Enea M, Giannetti A, Spatola F, Marchesini G, Crax\u00ec A, Petta S (2020) Association between PNPLA3 rs738409 C>G variant and liver-related outcomes in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 18:935-944.e933","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3758_CR52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.29113","volume":"66","author":"A Unalp-Arida","year":"2017","unstructured":"Unalp-Arida A, Ruhl CE (2017) Liver fibrosis scores predict liver disease mortality in the United States population. Hepatology 66:84\u201395","journal-title":"Hepatology"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03758-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-024-03758-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03758-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T12:37:39Z","timestamp":1738672659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-024-03758-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3758"],"URL":"https:\/\/doi.org\/10.1007\/s11739-024-03758-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4459086\/v1","asserted-by":"object"}]},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board of Samsung Medical Center (approval no. SMC 2019\u201311-051), Seoul, Republic of Korea. The researchers cannot identify any participant in order to obtain informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}